CapMan hosted its CMD event today in Helsinki. The company shared insights into its current state, a...
With production now commenced at the 110MW Waste to Energy (WtE) plant in Finland, generating its fi...
EcoRub (”EcoRub” eller ”Bolaget”) levererar unika material där affärsidén är att förädla återvunnen ...
Cantargia has announced that it has completed recruiting patients (n=102) for the randomised Phase I...
Luxbright AB (”Luxbright” eller ”Bolaget”) meddelade den 10 mars 2025 att Bolaget har förlängt samar...
Redeye returns with an update following Alzecure's Q4 report.
Redeye updates on Maximum Entertainment following Q4-results which saw softer topline than expected ...
Redeye leaves a short comment on WntResearch’s extraordinary general meeting.
Safello has announced it intends to launch of exchange-traded products (ETPs), a pivotal step to div...
Systemair överraskar med en stark organisk tillväxt på 5,4 procent under det tredje kvartalet, övert...
ODI Pharma AB:s (”ODI Pharma” or the ”Company”) past two quarters has been affected by import restri...
Q4: DKK 155m SDR impairment, adj. EBIT slightly better vs.
Redeye endorses Ortoma’s received CE certification for OTS Hip Guide in accordance with MDR.
Organic sales decline of 12% y-o-y EBIT margin of 2.
Redeye comments on the announcement of a SEK34.1m rights issue of shares.
